Yes, but do not start both on the same day
Abstract Study Objectives: To assess the effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dual gastric inhibitory polypeptide/GLP-1 receptor agonists in the treatment of obstructive sleep apnea
There's no rebound effect or withdrawal period
If you have medical conditions or take prescription medications, consult your healthcare provider
Oral Contraceptives : Tirzepatide can reduce their effectiveness by up to 55%, increasing pregnancy risks
We do not believe that bariatric surgery will continue to develop into a widely used treatment strategy to treat the majority of patients 50 years from now, given the peri-interventional mortality and morbidity risks, malabsorptive problems and other complications